Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Nov;69(2):126-32.
doi: 10.1007/s00253-005-0159-7. Epub 2005 Nov 12.

Microbial Fibrinolytic Enzymes: An Overview of Source, Production, Properties, and Thrombolytic Activity in Vivo

Affiliations
Review

Microbial Fibrinolytic Enzymes: An Overview of Source, Production, Properties, and Thrombolytic Activity in Vivo

Yong Peng et al. Appl Microbiol Biotechnol. .

Abstract

Accumulation of fibrin in the blood vessels usually results in thrombosis, leading to myocardial infarction and other cardiovascular diseases. For thrombolytic therapy, microbial fibrinolytic enzymes have now attracted much more attention than typical thrombolytic agents because of the expensive prices and the undesirable side effects of the latter. The fibrinolytic enzymes were successively discovered from different microorganisms, the most important among which is the genus Bacillus from traditional fermented foods. The physiochemical properties of these enzymes have been characterized, and their effectiveness in thrombolysis in vivo has been further identified. Therefore, microbial fibrinolytic enzymes, especially those from food-grade microorganisms, have the potential to be developed as functional food additives and drugs to prevent or cure thrombosis and other related diseases.

Similar articles

See all similar articles

Cited by 22 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback